Someya Eriko, Mori Asami, Sakamoto Kenji, Ishii Kunio, Nakahara Tsutomu
Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
Eur J Pharmacol. 2017 May 15;803:124-129. doi: 10.1016/j.ejphar.2017.03.043. Epub 2017 Mar 22.
Opioids contribute to the regulation of cerebral vascular tone. The purpose of this study was to examine the effects of herkinorin, a non-opioid μ-opioid receptor agonist derived from salvinorin A, on blood vessels in the rat retina and to investigate the mechanism underlying the herkinorin-induced retinal vasodilatory response. Ocular fundus images were captured using an original high-resolution digital fundus camera in vivo. The retinal vascular responses were evaluated by measuring the diameter of retinal arterioles in the fundus images. Both systemic blood pressure and heart rate were continuously recorded. Herkinorin increased the retinal arteriolar diameter without significantly changing mean blood pressure and heart rate. The retinal vasodilator response to herkinorin was almost completely prevented following treatment with naloxone, a nonselective opioid receptor antagonist and H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH (CTOP), a selective μ-opioid receptor antagonist. N-nitro-L-arginine methyl ester, a nonselective nitric oxide (NO) synthase inhibitor, or indomethacin, a cyclooxygenase inhibitor, significantly attenuated the herkinorin-induced retinal vasodilator responses. In addition, N-propyl-L-arginine, an inhibitor of neuronal NO synthase, diminished the herkinorin-induced retinal vasodilator responses. Seven days after an intravitreal injection of N-methyl-D-aspartic acid, loss of inner retinal neurons and abolishment of the retinal vasodilator response to herkinorin were observed. These results suggest that herkinorin dilates rat retinal arterioles through stimulation of retinal μ-opioid receptors. The μ-opioid receptor-mediated retinal vasodilator response is likely mediated by NO generated by neuronal NO synthase. Retinal neurons play an important role in the retinal vasodilator mechanism involving μ-opioid receptors in rats.
阿片类药物有助于调节脑血管张力。本研究的目的是研究源自鼠尾草酸的非阿片类μ-阿片受体激动剂赫基诺林对大鼠视网膜血管的影响,并探讨赫基诺林诱导视网膜血管舒张反应的潜在机制。使用原始的高分辨率数字眼底相机在体内采集眼底图像。通过测量眼底图像中视网膜小动脉的直径来评估视网膜血管反应。连续记录系统血压和心率。赫基诺林增加了视网膜小动脉直径,而平均血压和心率没有明显变化。用非选择性阿片受体拮抗剂纳洛酮和选择性μ-阿片受体拮抗剂H-D-苯丙氨酸-半胱氨酸-酪氨酸-D-色氨酸-鸟氨酸-苏氨酸-青霉胺-苏氨酸-NH(CTOP)处理后,对赫基诺林的视网膜血管舒张反应几乎完全被阻断。非选择性一氧化氮(NO)合酶抑制剂N-硝基-L-精氨酸甲酯或环氧化酶抑制剂吲哚美辛显著减弱了赫基诺林诱导的视网膜血管舒张反应。此外,神经元型NO合酶抑制剂N-丙基-L-精氨酸减少了赫基诺林诱导的视网膜血管舒张反应。玻璃体内注射N-甲基-D-天冬氨酸7天后,观察到视网膜内层神经元丢失以及对赫基诺林的视网膜血管舒张反应消失。这些结果表明,赫基诺林通过刺激视网膜μ-阿片受体使大鼠视网膜小动脉扩张。μ-阿片受体介导的视网膜血管舒张反应可能由神经元型NO合酶产生的NO介导。视网膜神经元在大鼠涉及μ-阿片受体的视网膜血管舒张机制中起重要作用。